Date:3/4/2013

3
5.4 Contract Manufacturing Market for Vaccines 2013-2023
5.4.1 Market Size for Contract Manufacturing of Vaccines 2011
5.4.2 Vaccine Contract Manufacturing Market Forecast 2013-2023
5.5 Leading Vaccine Contract Manufacturing Organisations
5.5.1 Baxter BioPharma Solutions
5.5.2 Boehringer Ingelheim
5.5.2.1 Recent Financial Performance
5.5.2.2 Ben Venue Laboratories
5.5.2.3 Manufacturing Deals 2011-2012
5.5.2.4 Outlook
5.5.3 Catalent
5.5.3.1 Recent Financial Performance
5.5.3.2 Strong Growth for Oral Delivery Technologies
5.5.3.3 Catalent Injectable Vaccines
5.5.3.4 Catalent Adjusts its Services
5.5.3.5 Outlook
5.5.4 Charles River Laboratories
5.5.4.1 Revenue Analysis 2006-2011
5.5.4.2 Vaccine Manufacturing Services
5.5.4.3 Charles River Avian Vaccine Services
5.5.4.4 Outlook and Early Stage Restructuring
5.5.5 IDT Biologika GmbH
5.5.6 Lonza
5.5.6.1 Recent Financial Performance
5.5.6.2 Lonza: Biologics and Vaccines
5.5.6.3 Outlook
5.5.7 Meridian Life Science
5.5.7.1Revenue Analysis
5.5.8 SAFC (Sigma-Aldrich Fine Chemicals)
5.5.8.1 SAFC Revenue Analysis
5.5.9 SynCo Bio Partners

6. Leading National Markets 2013-2023
6.1 The US, Europe and Japan are the Largest Markets for Vaccines
6.2 The US Vaccine Market Forecast 2013-2023
6.2.1 The US National Vaccination Plan
6.2.2 Challenges in the US Vaccines Market
6.2.3 CMO Services in the US
6.3 The EU5 Vaccine Market Forecast 2013-2023
6.3.1 The EU5: Trends in CMO Services for Vaccine Manufacturing
6.3.2 The German Vaccine Market Forecast 2013-2023
6.3.3 The French Vaccine Market Forecast 2013-2023
6.3.4 The UK Vaccine Market Forecast 2013-2023
6.3.5 The Spanish Vaccine Market Forecast 2013-2023
6.3.6 The Italian Vaccine Market Forecast 2013-2023
6.4 The Japanese Vaccine Market
6.4.1 The Ja
'/>"/>

SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related medicine technology :

1. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
2. Shingles Vaccine is Safe, According to New Study
3. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
4. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
5. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
6. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
7. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
8. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
9. Global Human Vaccines Industry
10. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
11. HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine